We're in a consolidation pattern. The bio space sector is seeing some headwinds. I believe we could trade between 4.50 and 5 until we get some news. TA is not necessarily the best tale of the tape on small caps as their news driven. Although, the daily chart and tools like the MACD and RSI can help explain accumulation and distribution. Remember folks their is a big difference between trading and investing. If you like the story here and have conviction hold it and potentially add on pullbacks. Regarding all the short bashers / the fact is that people rattling the tree on this board might control .00001% of the float thus there just bullies and nothing more . put them on ignore. Yet, I must admit their are a lot of posts about the stock going to 20 and greater. those are concerning to me as I'm a contrarian by nature. The bottom line is if you did you DD and have true conviction then stay the course. God bless.
looks like we might base above 4 as we await news. Happy New Year.. blessings everyone.
Dips are being bought. Held back. I think Sub 5 days are gone as of Monday. Yet, I'm often wrong just as my wife and son. Have a great weekend everyone. Blessings from Cabo.
todays leg down is on low volume. X MAS week usually has tons of volatility as traders are gone for the week. The GILD sell off does play a factor. Yet, my hunch is we close above 4 . The fundamentals have not changed. just some shaking of the tree.
Board Members, Upon reading about the newly registered trial on clinical. gov. I contacted Mr. Wiklund from CLDN IR DEPT. Please see his below response. I omitted a couple sentences that were not pertinent to the subject matter. He states as you can read below its normal protocol to test higher dosages to determine potential toxicity levels in a new therapy. As, the current dosage has not shown any safety issues. In my humble opinion this is still a risk on FDA event in April. As, his response to me does not speak to the efficacy in the current trial only the safety profile. Hopefully we will get more information on Tuesday. Please do your own due diligence. Blessings.
I was surprised to find that via Clinical.gov that a 36 person mydicar trial thats gated to start April with a dosage 2.5x that of CUPID.What is extremely concerning is if this is a signal that the efficacy in the current trial end points will be too low for the FDA.
With respect to the higher dose trial, we have not seen any dose limiting toxicities, safety concerns, or lab abnormalities with our current dose. Our DSMB has met four times during the CUPID trial without safety concerns. Proper Drug development then argues to initiate small scale studies to explore what a dose limiting tox may be. Particularly with a novel, first in man, gene therapy.
Fredrik Wiklund Less
your analysis is legit. Debt is high no doubt. my concern is the euro economy and if patrons of these events make the disposal income to return year after year. Their glorified raves which seems to have crested in popularity. from a technical perspective the daily chart seems to be improving on the volume spikes from inside buys , yet the MACD and RSI still need work. I wouldn't fall in love here but if you want to park some risk capitol with a stop under 4 its not a terrible idea. The talk of a secondary is always scary yet I don't see it here in the near term. Listen you got 2 EX goldman guys running this CO. They know how to play the debt markets. which is a huge plus, regardless of the what you think of GS my humble 2 cents.
I get the same feeling from the tape. being held back . its churning in a pretty tight range. the dips are being bought which you can see in the volume. Yet, profits are being taken. people are trading the channel right now and will do so until we breakout of this range. the baker boys buy the other day should put some floor on it. good news will pop this out of the channel and establish a new base. we're heading to 40 plus . patience will be rewarded. I have no problem cost averaging on the dips in the mid 33's. good luck and happy holidays
My gut is telling me they will release PARTNER news in the near future. My gut is bring driven by the recent cleaning up of the capitol table and the bringing in of a new CEO. My other point of enthusiasm is coming from the fact that ISIS sports a 7bb plus market cap and IDRA has new improved technology plus a staple of other ground breaking breakthroughs.
Ranger... shares are scarce.. I'm long yet your post seems unfounded. plenty of shares in the float for sale and another 90mm on the shelf to pour into the float... I mean NO disrespect. happy holidays
the bakers are not doing it. remember market makers control tons of shares that they can trade amongst accounts. yet, that's all tea leave stuff. this is a story stock that's going to really move on news. bottom line. best to own shares that your comfortable owning regardless of the daily tape and let it ride . perhaps with a stop below the 52 wk low. just in case we get a bad chapter...
thank you. I was referring to partners not investors. Was SUMO included in the phase 1 clinical trials ? or was it done via only using the SERCA compound ?
I believe the author of the below article really captured the story. Yet, he's a making a case for CLDN on the long side. Always do your own due diligence. Never allow someone to make your trading / investing decisions for you. You've worked hard for your capitol. Protect it.